Nabil Asaad, PhD

Senior associate

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

Show full CV Hide full CV

Latest news & insights

Laboratory pipettes
Life sciences & healthcare

Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis

29 October 2021

by Colin McCall and Nabil Asaad, PhD

Click here to find out more
White microscope on yellow background
Technology, media & communications

Life sciences and healthcare in 2022 – legislators at work

3 December 2021
Briefing

by Alison Dennis and Justyna Ostrowska

Click here to find out more
Analogue Tachograph disc
Disputes & investigations

The Traffic Light Coalition agrees to the legalisation of cannabis products as outlined in the new Coalition Agreement

3 December 2021
Briefing

by Dr. Daniel Tietjen

Click here to find out more
Robots hand
Artificial intelligence & machine learning

Artificial Intelligence Act (AIA) - Legal uncertainty for medical device manufacturers

30 November 2021
Briefing

by Dr. Daniel Tietjen and Dr. Niclas von Woedtke, MBA (Kellogg/ WHU)

Click here to find out more

Related people

Meet me at

There are no upcoming events